Connect with us

Health

Cat antiviral that inhibits SARS-CoV-2 fast-tracked for human clinical trials – News-Medical.Net

Now, a team of researchers at the University of Alberta in Canada has identified viral inhibitors that they claim are potential candidates as a treatment for COVID-19. The team is set to launch clinical trials of the drug that is used as a treatment for a typ…

Published

on

The coronavirus disease (COVID-19) pandemic has affected most countries worldwide, and with eight months passed since the virus first emerged, there are still no approved drugs or vaccines against it. Many clinicians have used antivirals intended for other infections in the hope that they will work against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.
Now, a team of researchers at the University of Alberta in Canada has identified viral inhibi…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending